Asthma is an inflammatory disease of the airways that is characterized by recurrent respiratory issues: episodes of coughing, wheezing, shortness of breath (dyspnoea), tightness in the chest. It is estimated that more than two and half million people in Italy suffer from asthma, while worldwide the number of asthma patients rises to around 300 million. […]
Read moreThe topic of gender equality and equal opportunities is one of the most pressing of our time. Especially in the scientific and pharmaceutical fields, the presence of women is still relatively limited. According to the UNESCO Institute for Statistics, women account for less than 30 % of researchers worldwide; moreover, women who pursue careers in […]
Read moreThe skin is our body’s largest organ and is made up of various tissues. It works as a touch point with the outside world and, at the same time, as a real anatomical barrier. Although the skin is extremely thin, it performs many functions, including providing protection for our body, acting as our first defense […]
Read moreThe Winter Olympics is an event that often sees Italian colors on the podium. The history of one of the most important sport events is strictly tied to the performances of Italian athletes, who frequently top the world rankings in various specialties. Italy won 17 Olympic medals at the Beijing 2022 Winter Olympics, second only […]
Read moreMenarini has been involved in ensuring health and well-being for over 135 years. An entrepreneurial history that has always put quality first, together with the constant search for innovative and sustainable production systems. Environmental awareness is a paramount topical element when researching development strategies. This is implemented through technological solutions that focus on the recovery […]
Read more28 February is universally recognised as World Rare Disease Day. This is a significant date for the Menarini Group, which counts among its core values the research on yet unresolved pathologies and infectious diseases, with particular attention to rare diseases. The Group is committed to the development of new therapies that can address the unmet […]
Read more